Sprott Physical Gold and Silver Trust (CEF)
After hours:
Chart Events
Performance Outlook
| Previous Close | 18.91 |
| Open | 18.92 |
| Bid | 18.91 x 1200 |
| Ask | 18.98 x 4000 |
| Day's Range | 18.86 - 18.99 |
| 52 Week Range | 15.11 - 20.14 |
| Volume | |
| Avg. Volume | 524,095 |
| Market Cap | 4.111B |
| Beta (5Y Monthly) | -0.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.25 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Oct 30, 2017 |
| 1y Target Est | N/A |
- GlobeNewswire
Wellbeing Digital Sciences Announces the Appointment of Natalie Dolphin as VP of Marketing and Investment Relations
Ms. Dolphin is a key strategic addition to the team, and will have an impact on the corporate strategy and growth opportunities of the companyVANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by
- GlobeNewswire
Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (JointAlive®) Supplementation in treating OA
VANCOUVER, British Columbia, June 17, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that a clinical study conducted by its wholly owned subsidiary KGK Sciences Inc. (“KGK”), has shown positive res
